Trial intelligence / Profile preview

Effects of Oxytocin on Social Touch

NCT05265806Completed

Sponsor
University of Electronic Science and Technology of China
Start
Sep 2021
Primary completion
Mar 2022
Countries
1
01

Overview

Randomised, double-blind trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD) (3 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoints: fNIRS based measures of touch processing and Ratings of pleasantness, arousal, intensity and payment. Started Sep 2021; status: completed.

02

Drugs

oxytocin nasal spray
03

Conditions

Autism Spectrum Disorder (ASD)

Beyond the preview

Go deeper on NCT05265806.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05265806.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call